The expression of Oct4 variants was evaluated in brain cancer cell lines, and in brain tumor tissues, by quantitative real-time PCR, western blotting, and immunohistochemical analysis.
[Neuro-Oncology]
Home Newsletters Cancer Stem Cell News Oct4A Palmitoylation Modulates Tumorigenicity and Stemness in Human Glioblastoma Cells
